Header cover image

Spanish (IBEX) Pharma Industry Analysis

UpdatedDec 25, 2024
DataAggregated Company Financials
Companies5
  • 7D-0.1%
  • 3M-10.3%
  • 1Y2.1%
  • YTD0.2%

The Pharma industry has stayed flat over the last week. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Spanish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 25 Dec 2024€6.2b€2.7b€226.1m19.1x27.4x2.3x
Fri, 22 Nov 2024€6.2b€2.7b€226.1m19.2x27.6x2.4x
Sun, 20 Oct 2024€7.2b€2.5b€219.5m26.3x32.9x2.8x
Tue, 17 Sep 2024€7.0b€2.5b€219.5m23.4x32x2.8x
Thu, 15 Aug 2024€7.1b€2.5b€219.5m23.6x32.2x2.8x
Sat, 13 Jul 2024€7.7b€2.5b€202.7m24.2x38.2x3.1x
Mon, 10 Jun 2024€8.1b€2.6b€198.2m27.2x40.9x3.2x
Wed, 08 May 2024€7.5b€2.6b€226.5m21.5x32.9x2.9x
Fri, 05 Apr 2024€7.1b€2.6b€223.6m21.4x31.8x2.8x
Sun, 03 Mar 2024€6.7b€2.6b€223.6m21x30.1x2.6x
Tue, 30 Jan 2024€6.2b€2.6b€296.4m16.4x21x2.4x
Thu, 28 Dec 2023€6.2b€2.6b€296.4m15.7x20.8x2.4x
Sat, 25 Nov 2023€5.9b€2.6b€296.4m15.8x19.9x2.3x
Mon, 23 Oct 2023€5.6b€2.5b€274.5m14.2x20.4x2.3x
Wed, 20 Sep 2023€6.2b€2.5b€274.5m15.5x22.4x2.5x
Fri, 18 Aug 2023€5.7b€2.5b€274.5m13.9x20.9x2.3x
Sun, 16 Jul 2023€4.7b€2.4b€284.3m11x16.7x2x
Tue, 13 Jun 2023€5.1b€2.4b€284.3m12x18.1x2.1x
Thu, 11 May 2023€5.1b€2.4b€289.9m11.4x17.5x2.1x
Sat, 08 Apr 2023€5.0b€2.4b€301.6m17.4x16.5x2.1x
Mon, 06 Mar 2023€5.1b€2.4b€301.6m18.8x16.9x2.1x
Wed, 01 Feb 2023€5.0b€2.3b€275.8m30.6x18.3x2.1x
Fri, 30 Dec 2022€4.9b€2.3b€275.8m26.6x17.7x2.1x
Sun, 27 Nov 2022€5.0b€2.3b€276.7m26.9x18x2.1x
Tue, 25 Oct 2022€5.3b€2.3b€306.3m22.5x17.3x2.3x
Thu, 22 Sep 2022€5.4b€2.3b€306.3m24.5x17.6x2.3x
Sat, 20 Aug 2022€6.0b€2.3b€306.3m28.3x19.5x2.6x
Mon, 18 Jul 2022€6.8b€2.3b€225.4m17.8x30.1x3x
Wed, 15 Jun 2022€6.1b€2.3b€225.4m16.4x27x2.7x
Fri, 13 May 2022€6.7b€2.2b€200.5m22x33.4x3.1x
Sun, 10 Apr 2022€7.4b€2.1b€200.5m25x37x3.5x
Tue, 08 Mar 2022€6.8b€2.1b€200.5m24x34x3.2x
Thu, 03 Feb 2022€7.1b€2.0b€177.1m33.6x40.2x3.5x
Sat, 01 Jan 2022€7.4b€2.0b€177.1m36.6x42x3.6x
Price to Earnings Ratio

42x


Total Market Cap: €7.4bTotal Earnings: €177.1mTotal Revenue: €2.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Pharma Industry Price to Earnings3Y Average 26x202220232024
Current Industry PE
  • Investors are relatively neutral on the Spanish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 26.0x.
  • The 3-year average PS ratio of 2.6x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 8.5% per year over the last three years.
  • Revenues for these companies have grown 9.1% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Spanish Healthcare industry?

ES Market-0.86%
Healthcare-1.90%
Pharma-0.13%
Pharma-0.13%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROVI Laboratorios Farmaceuticos Rovi€61.700.4%
+€12.8m
3.6%PE19.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.